Web Analytics
DFTX (NASDAQ) 株価分析 | DEFINIUM THERAPEUTICS, INC. – Deepscope
MARKET

Select Market Data Region

DFTX 株価分析 — Definium Therapeutics, Inc. (Healthcare >> Biotechnology)

DFTX に関するよくある質問

DFTXのROE(自己資本利益率)は?

Definium Therapeutics, Inc.のROEは-85.19%です。

DFTXの配当利回りは?

Definium Therapeutics, Inc.の配当利回りは0.00%です。

DFTXの品質スコア(Quality Score)は?

当社のAIはDFTXの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

DFTXは今が買い時ですか?

当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

DFTXはどのセクターに属しますか?

Definium Therapeutics, Inc.はHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-08-03 | FS: 2026-03-31)

DFTX AI Analysis Summary

Our AI summary for DFTX: Definium Therapeutics, Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -85.19%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

DFTX

Definium Therapeutics, Inc.
USD 41.79
-1.73 (-3.98%) Day Change
0.15
D/E
-85.2%
ROE
-59.2%
ROA
0.00%
Div Yield

DEFINIUM THERAPEUTICS, INC.
TYPE: STOCK
MARKET: NASDAQ

Compare   Watchlist   Myport
USD 41.79
Price
-1.73 (-3.98%)
Day Change
NEWS SCORE: 90

DFTX, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...

23

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...

Deepscope 分析 45%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 90
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 41.79
  PBV / Sector
20.72 / 44,219.29
  Earning Per Share -1.72
  PE / Sector
N/A / 19.28
  PEG or PE/Growth / Sector
N/A / 1.23
  Average 1M Daily Value
82.03 M
  Average 1W Daily Value
79.88 M
Timing Factors 71%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 37%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
N/A / 98.22
  NPM Average (%) / Sector
N/A / -1,697.63
  NPM Change Average (%) / Sector
N/A / 5,097.97
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-59.19 / 185,260.96
  ROA Average (%) / Sector
-49.44 / 36,684.70
  ROA Change Average (%) / Sector
33.68 / 422,221.66
GREAT
  ROE (%) / Sector
-85.19 / 243,762.23
  ROE Average (%) / Sector
-69.13 / 48,758.47
  ROE Change Average (%) / Sector
59.80 / 424,968.10
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 0.04
  Dividend Average (%) / Sector
N/A / 17.04
  Dividend Change Average (%) / Sector
N/A / -0.19
登録情報
X
  Analyze Date 2026-08-04 08:01:24
  Symbol DFTX
  Name DEFINIUM THERAPEUTICS, INC.
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 132.74 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 5,776.99 / 9,645.64
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: One World Trade Center, New York, NY, United States, 10007

Phone: 212 220 6633

Website: https://definiumtx.com

Employees: 105

Sector: Healthcare >> Biotechnology

Description: Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Biotechnology

DFTX (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

同業種の銘柄

Healthcare › Biotechnology

同じ基準で分析・時価総額順

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
DFTX
DFTX
USD 41.79 (-3.98%)
+ Watch + Port Chart